AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $254,000 | -86.7% | 8,986 | -84.5% | 0.03% | -85.8% |
| Q4 2021 | $1,908,000 | +210.7% | 58,059 | +230.8% | 0.24% | +135.3% |
| Q3 2020 | $614,000 | +61.2% | 17,552 | +49.2% | 0.10% | +96.2% |
| Q3 2019 | $381,000 | +1.6% | 11,764 | +56.3% | 0.05% | +23.8% |
| Q2 2019 | $375,000 | +43.1% | 7,528 | +121.4% | 0.04% | +200.0% |
| Q3 2018 | $262,000 | +18.6% | 3,400 | +8.5% | 0.01% | +27.3% |
| Q3 2015 | $221,000 | -81.5% | 3,134 | -70.8% | 0.01% | -76.1% |
| Q2 2015 | $1,193,000 | -59.7% | 10,734 | -65.8% | 0.05% | -61.0% |
| Q1 2015 | $2,958,000 | – | 31,367 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |